C.C. Leung
Vice Chairman and PresidentQuanta Computer
ChairView Profile →Board co-Chair, President and Chief Scientific Officer · Regeneron Pharmaceuticals
George D. Yancopoulos is board co-chair, president and chief scientific officer of Regeneron Pharmaceuticals. He joined the company’s founding scientific effort in 1989 and has helped develop its antibody and genetic engineering technologies, following an academic career in molecular immunology at Columbia University.
Last reviewed: Oct 21, 2026
Board co-Chair, President and Chief Scientific Officer Regeneron Pharmaceuticals
Last Reviewed: October 21, 2026
George D. Yancopoulos is board co-chair, president and chief scientific officer of Regeneron Pharmaceuticals. He joined the company’s founding scientific effort in 1989 and has helped develop its antibody and genetic engineering technologies, following an academic career in molecular immunology at Columbia University.
Yancopoulos developed his scientific career at Columbia University, where he worked with Frederick Alt and published research in molecular immunology. He left academia in 1989 to join Leonard Schleifer in building Regeneron’s scientific organization.
His work connects basic research with technologies used to discover and develop medicines. The company identifies him and his teams with its soluble receptor Trap technology, VelociGene genetic engineering system and VelocImmune human antibody platform. Those technologies support a broader drug development effort across eye disease, inflammatory conditions, oncology and infectious disease.
He continues to lead as president and chief scientific officer, alongside his board co-chair position established in 2023. His scientific recognition includes election to the National Academy of Sciences and induction into the Biotech Hall of Fame. Product and platform development remain collaborative achievements rather than the work of a single scientist.
His interest in science education is linked to his own participation in the Westinghouse Science Talent Search as a high school student. Regeneron’s biography describes his involvement in its support for the current Regeneron Science Talent Search and International Science and Engineering Fair, programs intended to encourage young researchers.
Yancopoulos earned a BA in biochemistry from Columbia College, an MD from Columbia University’s College of Physicians and Surgeons, and a PhD in biochemistry and molecular biophysics from Columbia University.